facebook pixel
chevron_right Health
transparent transparent
Thousands of breast cancer gene variants engineered and analyzed: Findings will be immediately useful to many patients with previously inconclusive genetic test results -
A new scientific analysis of nearly 4,000 mutations deliberately engineered into the BRCA1 gene will immediately benefit people undergoing genetic testing for breast or ovarian cancer risk. Many women undergoing genetic screening for breast and ovarian cancer learn that their BRCA1 gene contains a variant of uncertain significance. These variants of uncertain significance, the scientists wrote in their report, fundamentally limit the clinical utility of a patient's genetic information.
For the best experience use Awesummly app on your Android phone
Awesummly Chrome Extension Awesummly Android App